Which closed-end funds own Bridgebio Pharma Inc?
6 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $18.9M. Security type: debt security. Country: United States. CUSIP 10806XAD4 · ISIN US10806XAD49.
Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| NCZ Virtus Convertible & Income Fund II | Convertible Securities | 0.82% | $3.8M | 3,345,000 par | $463M | 7.6% discount | Jul 31, 2026 |
| NCV Virtus Convertible & Income Fund | Convertible Securities | 0.79% | $4.8M | 4,190,000 par | $601M | 9.6% discount | Jul 31, 2026 |
| ACV Virtus Diversified Income & Convertible Fund | Convertible Securities | 0.75% | $2.8M | 2,500,000 par | $380M | 5.3% discount | Jul 31, 2026 |
| NIE Virtus Equity & Convertible Income Fund | Convertible Securities | 0.48% | $3.7M | 3,295,000 par | $786M | 9.5% discount | Jul 31, 2026 |
| NFJ Virtus Dividend, Interest & Premium Strategy Fund | U.S. Equity | 0.25% | $3.7M | 3,275,000 par | $1.5B | 9.0% discount | Jul 31, 2026 |
| VGI Virtus Global Multi-Sector Income Fund | Multi-Asset | 0.01% | $9.7K | 9,000 par | $129M | 10.8% discount | May 29, 2026 |
6 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Bridgebio Pharma Inc | common equity | 8 |
| Bridgebio Pharma Inc | debt security | 7 |
| Bridgebio Pharma Inc | debt security | 4 |
| Bridgebio Pharma Inc | debt security | 1 |
Issuer-level search for “BRIDGEBIO PHARMA INC” → · Compare two funds’ portfolios →